TP53 and myelodysplastic syndrome: De-Morgan et al. studied the genomic data of 2773 MDS patients and showed that men have higher incidence of U2AF1 and ZSRS2 mutations whereas women with MDS have higher incidence of DNMT3A and TP53 mutations [8].